Selected research
Market Outlook & Growth Opportunities
Global CRISPR-Cas9 Gene Editing Service Market Outlook and Growth Opportunities 2026
Market perspective
The global CRISPR-Cas9 Gene Editing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for CRISPR-Cas9 Gene Editing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for CRISPR-Cas9 Gene Editing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for CRISPR-Cas9 Gene Editing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the CRISPR-Cas9 Gene Editing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the CRISPR-Cas9 Gene Editing Service market include AMSBIO, GenScript, Merck, Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, DefiniGEN, Synthego and Biocytogen, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global CRISPR-Cas9 Gene Editing Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of CRISPR-Cas9 Gene Editing Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents CRISPR-Cas9 Gene Editing Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global CRISPR-Cas9 Gene Editing Service market.
CRISPR-Cas9 Gene Editing Service Segment by Company
AMSBIO
GenScript
Merck
Editas Medicine
Intellia Therapeutics
CRISPR Therapeutics
DefiniGEN
Synthego
Biocytogen
Caribou
Horizon Discovery Ltd.
EdiGene, Inc.
DetaiBio
CRISPR-Cas9 Gene Editing Service Segment by Type
Knock-in Gene Editing Service
Knock-out Gene Editing Service
Other
CRISPR-Cas9 Gene Editing Service Segment by Application
Cell Line Construction
Animal Models
Bioagriculture
Other
CRISPR-Cas9 Gene Editing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global CRISPR-Cas9 Gene Editing Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the CRISPR-Cas9 Gene Editing Service key companies, revenue, market share, and recent developments.
3. To split the CRISPR-Cas9 Gene Editing Service breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions CRISPR-Cas9 Gene Editing Service market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify CRISPR-Cas9 Gene Editing Service significant trends, drivers, influence factors in global and regions.
6. To analyze CRISPR-Cas9 Gene Editing Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global CRISPR-Cas9 Gene Editing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of CRISPR-Cas9 Gene Editing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of CRISPR-Cas9 Gene Editing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global CRISPR-Cas9 Gene Editing Service industry.
Chapter 3: Detailed analysis of CRISPR-Cas9 Gene Editing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of CRISPR-Cas9 Gene Editing Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of CRISPR-Cas9 Gene Editing Service in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
List of Tables
Table 1. CRISPR-Cas9 Gene Editing Service Industry Trends
Table 2. CRISPR-Cas9 Gene Editing Service Industry Drivers
Table 3. CRISPR-Cas9 Gene Editing Service Industry Opportunities and Challenges
Table 4. CRISPR-Cas9 Gene Editing Service Industry Restraints
Table 5. Global CRISPR-Cas9 Gene Editing Service Revenue by Company (US$ Million) & (2021-2026)
Table 6. Global CRISPR-Cas9 Gene Editing Service Revenue Share by Company (2021-2026)
Table 7. Global CRISPR-Cas9 Gene Editing Service Company Ranking, (2024-2026) & (US$ Million)
Table 8. Global CRISPR-Cas9 Gene Editing Service Key Company Manufacturing Base & Headquarters
Table 9. Global CRISPR-Cas9 Gene Editing Service Company, Product Type & Application
Table 10. Global CRISPR-Cas9 Gene Editing Service Company Establishment Date
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global CRISPR-Cas9 Gene Editing Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Significant Companies of Knock-in Gene Editing Service
Table 15. Significant Companies of Knock-out Gene Editing Service
Table 16. Significant Companies of Other
Table 17. Global CRISPR-Cas9 Gene Editing Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 18. Global CRISPR-Cas9 Gene Editing Service Sales Value by Type (2021-2026) & (US$ Million)
Table 19. Global CRISPR-Cas9 Gene Editing Service Sales Value by Type (2027-2032) & (US$ Million)
Table 20. Global CRISPR-Cas9 Gene Editing Service Sales Value Share by Type (2021-2026)
Table 21. Global CRISPR-Cas9 Gene Editing Service Sales Value Share by Type (2027-2032)
Table 22. Significant Companies of Cell Line Construction
Table 23. Significant Companies of Animal Models
Table 24. Significant Companies of Bioagriculture
Table 25. Significant Companies of Other
Table 26. Global CRISPR-Cas9 Gene Editing Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 27. Global CRISPR-Cas9 Gene Editing Service Sales Value by Application (2021-2026) & (US$ Million)
Table 28. Global CRISPR-Cas9 Gene Editing Service Sales Value by Application (2027-2032) & (US$ Million)
Table 29. Global CRISPR-Cas9 Gene Editing Service Sales Value Share by Application (2021-2026)
Table 30. Global CRISPR-Cas9 Gene Editing Service Sales Value Share by Application (2027-2032)
Table 31. Global CRISPR-Cas9 Gene Editing Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 32. Global CRISPR-Cas9 Gene Editing Service Sales Value by Region (2021-2026) & (US$ Million)
Table 33. Global CRISPR-Cas9 Gene Editing Service Sales Value Share by Region (2021-2026)
Table 34. Global CRISPR-Cas9 Gene Editing Service Sales Value by Region (2027-2032) & (US$ Million)
Table 35. Global CRISPR-Cas9 Gene Editing Service Sales Value Share by Region (2027-2032)
Table 36. Global CRISPR-Cas9 Gene Editing Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Global CRISPR-Cas9 Gene Editing Service Sales Value by Country (2021-2026) & (US$ Million)
Table 38. Global CRISPR-Cas9 Gene Editing Service Sales Value Market Share by Country (2021-2026)
Table 39. Global CRISPR-Cas9 Gene Editing Service Sales Value by Country (2027-2032) & (US$ Million)
Table 40. Global CRISPR-Cas9 Gene Editing Service Sales Value Market Share by Country (2027-2032)
Table 41. AMSBIO Company Information
Table 42. AMSBIO Business Overview
Table 43. AMSBIO CRISPR-Cas9 Gene Editing Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 44. AMSBIO CRISPR-Cas9 Gene Editing Service Product Portfolio
Table 45. AMSBIO Recent Development
Table 46. GenScript Company Information
Table 47. GenScript Business Overview
Table 48. GenScript CRISPR-Cas9 Gene Editing Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 49. GenScript CRISPR-Cas9 Gene Editing Service Product Portfolio
Table 50. GenScript Recent Development
Table 51. Merck Company Information
Table 52. Merck Business Overview
Table 53. Merck CRISPR-Cas9 Gene Editing Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 54. Merck CRISPR-Cas9 Gene Editing Service Product Portfolio
Table 55. Merck Recent Development
Table 56. Editas Medicine Company Information
Table 57. Editas Medicine Business Overview
Table 58. Editas Medicine CRISPR-Cas9 Gene Editing Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 59. Editas Medicine CRISPR-Cas9 Gene Editing Service Product Portfolio
Table 60. Editas Medicine Recent Development
Table 61. Intellia Therapeutics Company Information
Table 62. Intellia Therapeutics Business Overview
Table 63. Intellia Therapeutics CRISPR-Cas9 Gene Editing Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 64. Intellia Therapeutics CRISPR-Cas9 Gene Editing Service Product Portfolio
Table 65. Intellia Therapeutics Recent Development
Table 66. CRISPR Therapeutics Company Information
Table 67. CRISPR Therapeutics Business Overview
Table 68. CRISPR Therapeutics CRISPR-Cas9 Gene Editing Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 69. CRISPR Therapeutics CRISPR-Cas9 Gene Editing Service Product Portfolio
Table 70. CRISPR Therapeutics Recent Development
Table 71. DefiniGEN Company Information
Table 72. DefiniGEN Business Overview
Table 73. DefiniGEN CRISPR-Cas9 Gene Editing Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 74. DefiniGEN CRISPR-Cas9 Gene Editing Service Product Portfolio
Table 75. DefiniGEN Recent Development
Table 76. Synthego Company Information
Table 77. Synthego Business Overview
Table 78. Synthego CRISPR-Cas9 Gene Editing Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 79. Synthego CRISPR-Cas9 Gene Editing Service Product Portfolio
Table 80. Synthego Recent Development
Table 81. Biocytogen Company Information
Table 82. Biocytogen Business Overview
Table 83. Biocytogen CRISPR-Cas9 Gene Editing Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 84. Biocytogen CRISPR-Cas9 Gene Editing Service Product Portfolio
Table 85. Biocytogen Recent Development
Table 86. Caribou Company Information
Table 87. Caribou Business Overview
Table 88. Caribou CRISPR-Cas9 Gene Editing Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 89. Caribou CRISPR-Cas9 Gene Editing Service Product Portfolio
Table 90. Caribou Recent Development
Table 91. Horizon Discovery Ltd. Company Information
Table 92. Horizon Discovery Ltd. Business Overview
Table 93. Horizon Discovery Ltd. CRISPR-Cas9 Gene Editing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 94. Horizon Discovery Ltd. CRISPR-Cas9 Gene Editing Service Product Portfolio
Table 95. Horizon Discovery Ltd. Recent Development
Table 96. EdiGene, Inc. Company Information
Table 97. EdiGene, Inc. Business Overview
Table 98. EdiGene, Inc. CRISPR-Cas9 Gene Editing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 99. EdiGene, Inc. CRISPR-Cas9 Gene Editing Service Product Portfolio
Table 100. EdiGene, Inc. Recent Development
Table 101. DetaiBio Company Information
Table 102. DetaiBio Business Overview
Table 103. DetaiBio CRISPR-Cas9 Gene Editing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 104. DetaiBio CRISPR-Cas9 Gene Editing Service Product Portfolio
Table 105. DetaiBio Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Authors List of This Report
Table 108. Secondary Sources
Table 109. Primary Sources
List of Figures
Figure 1. CRISPR-Cas9 Gene Editing Service Product Image
Figure 2. Global CRISPR-Cas9 Gene Editing Service Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global CRISPR-Cas9 Gene Editing Service Market Size (2021-2032) & (US$ Million)
Figure 4. Global CRISPR-Cas9 Gene Editing Service Company Revenue Ranking in 2025 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 7. Knock-in Gene Editing Service Image
Figure 8. Knock-out Gene Editing Service Image
Figure 9. Other Image
Figure 10. Global CRISPR-Cas9 Gene Editing Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 11. Global CRISPR-Cas9 Gene Editing Service Sales Value Share 2021 VS 2025 VS 2032
Figure 12. Global CRISPR-Cas9 Gene Editing Service Sales Value Share by Type (2021-2032)
Figure 13. Cell Line Construction Image
Figure 14. Animal Models Image
Figure 15. Bioagriculture Image
Figure 16. Other Image
Figure 17. Global CRISPR-Cas9 Gene Editing Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 18. Global CRISPR-Cas9 Gene Editing Service Sales Value Share 2021 VS 2025 VS 2032
Figure 19. Global CRISPR-Cas9 Gene Editing Service Sales Value Share by Application (2021-2032)
Figure 20. Global CRISPR-Cas9 Gene Editing Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 21. Global CRISPR-Cas9 Gene Editing Service Sales Value Share by Region: 2021 VS 2025 VS 2032
Figure 22. North America CRISPR-Cas9 Gene Editing Service Sales Value (2021-2032) & (US$ Million)
Figure 23. North America CRISPR-Cas9 Gene Editing Service Sales Value Share by Country (%), 2025 VS 2032
Figure 24. Europe CRISPR-Cas9 Gene Editing Service Sales Value (2021-2032) & (US$ Million)
Figure 25. Europe CRISPR-Cas9 Gene Editing Service Sales Value Share by Country (%), 2025 VS 2032
Figure 26. Asia-Pacific CRISPR-Cas9 Gene Editing Service Sales Value (2021-2032) & (US$ Million)
Figure 27. Asia-Pacific CRISPR-Cas9 Gene Editing Service Sales Value Share by Country (%), 2025 VS 2032
Figure 28. South America CRISPR-Cas9 Gene Editing Service Sales Value (2021-2032) & (US$ Million)
Figure 29. South America CRISPR-Cas9 Gene Editing Service Sales Value Share by Country (%), 2025 VS 2032
Figure 30. Middle East & Africa CRISPR-Cas9 Gene Editing Service Sales Value (2021-2032) & (US$ Million)
Figure 31. Middle East & Africa CRISPR-Cas9 Gene Editing Service Sales Value Share by Country (%), 2025 VS 2032
Figure 32. USA CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 33. USA CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 34. USA CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 35. Canada CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 36. Canada CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 37. Canada CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 38. Mexico CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 39. Mexico CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 40. Mexico CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 41. Germany CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 42. Germany CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 43. Germany CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 44. France CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 45. France CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 46. France CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 47. U.K. CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 48. U.K. CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 49. U.K. CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 50. Italy CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 51. Italy CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 52. Italy CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 53. Spain CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 54. Spain CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 55. Spain CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 56. Russia CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 57. Russia CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 58. Russia CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 59. Netherlands CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 60. Netherlands CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 61. Netherlands CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 62. Nordic Countries CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 63. Nordic Countries CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 64. Nordic Countries CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 65. China CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 66. China CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 67. China CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 68. Japan CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 69. Japan CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 70. Japan CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 71. South Korea CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 72. South Korea CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 73. South Korea CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 74. India CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 75. India CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 76. India CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 77. Australia CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 78. Australia CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 79. Australia CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 80. Southeast Asia CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 81. Southeast Asia CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 82. Southeast Asia CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 83. Brazil CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 84. Brazil CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 85. Brazil CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 86. Argentina CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 87. Argentina CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 88. Argentina CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 89. Chile CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 90. Chile CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 91. Chile CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 92. Colombia CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 93. Colombia CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 94. Colombia CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 95. Peru CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 96. Peru CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 97. Peru CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 98. Saudi Arabia CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 99. Saudi Arabia CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 100. Saudi Arabia CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 101. Israel CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 102. Israel CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 103. Israel CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 104. UAE CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 105. UAE CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 106. UAE CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 107. Turkey CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 108. Turkey CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 109. Turkey CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 110. Iran CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 111. Iran CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 112. Iran CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 113. Egypt CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 114. Egypt CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 115. Egypt CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 116. Years Considered
Figure 117. Research Process
Figure 118. Key Executives Interviewed
Scope & coverage.
Types
- Knock-in Gene Editing Service
- Knock-out Gene Editing Service
- Other
Applications
- Cell Line Construction
- Animal Models
- Bioagriculture
- Other
Companies covered
- AMSBIO
- GenScript
- Merck
- Editas Medicine
- Intellia Therapeutics
- CRISPR Therapeutics
- DefiniGEN
- Synthego
- Biocytogen
- Caribou
- Horizon Discovery Ltd.
- EdiGene, Inc.
- DetaiBio
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global CRISPR-Cas9 Gene Editing Service Market Size, 2021 VS 2025 VS 2032
- 1.3 Global CRISPR-Cas9 Gene Editing Service Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 CRISPR-Cas9 Gene Editing Service Market Dynamics
- 2.1 CRISPR-Cas9 Gene Editing Service Industry Trends
- 2.2 CRISPR-Cas9 Gene Editing Service Industry Drivers
- 2.3 CRISPR-Cas9 Gene Editing Service Industry Opportunities and Challenges
- 2.4 CRISPR-Cas9 Gene Editing Service Industry Restraints
3 CRISPR-Cas9 Gene Editing Service Market by Company
- 3.1 Global CRISPR-Cas9 Gene Editing Service Company Revenue Ranking in 2025
- 3.2 Global CRISPR-Cas9 Gene Editing Service Revenue by Company (2021-2026)
- 3.3 Global CRISPR-Cas9 Gene Editing Service Company Ranking (2024-2026)
- 3.4 Global CRISPR-Cas9 Gene Editing Service Company Manufacturing Base and Headquarters
- 3.5 Global CRISPR-Cas9 Gene Editing Service Company Product Type and Application
- 3.6 Global CRISPR-Cas9 Gene Editing Service Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global CRISPR-Cas9 Gene Editing Service Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 CRISPR-Cas9 Gene Editing Service Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 CRISPR-Cas9 Gene Editing Service Market by Type
- 4.1 CRISPR-Cas9 Gene Editing Service Type Introduction
- 4.1.1 Knock-in Gene Editing Service
- 4.1.2 Knock-out Gene Editing Service
- 4.1.3 Other
- 4.2 Global CRISPR-Cas9 Gene Editing Service Sales Value by Type
- 4.2.1 Global CRISPR-Cas9 Gene Editing Service Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global CRISPR-Cas9 Gene Editing Service Sales Value by Type (2021-2032)
- 4.2.3 Global CRISPR-Cas9 Gene Editing Service Sales Value Share by Type (2021-2032)
5 CRISPR-Cas9 Gene Editing Service Market by Application
- 5.1 CRISPR-Cas9 Gene Editing Service Application Introduction
- 5.1.1 Cell Line Construction
- 5.1.2 Animal Models
- 5.1.3 Bioagriculture
- 5.1.4 Other
- 5.2 Global CRISPR-Cas9 Gene Editing Service Sales Value by Application
- 5.2.1 Global CRISPR-Cas9 Gene Editing Service Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global CRISPR-Cas9 Gene Editing Service Sales Value by Application (2021-2032)
- 5.2.3 Global CRISPR-Cas9 Gene Editing Service Sales Value Share by Application (2021-2032)
6 CRISPR-Cas9 Gene Editing Service Regional Value Analysis
- 6.1 Global CRISPR-Cas9 Gene Editing Service Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global CRISPR-Cas9 Gene Editing Service Sales Value by Region (2021-2032)
- 6.2.1 Global CRISPR-Cas9 Gene Editing Service Sales Value by Region: 2021-2026
- 6.2.2 Global CRISPR-Cas9 Gene Editing Service Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America CRISPR-Cas9 Gene Editing Service Sales Value (2021-2032)
- 6.3.2 North America CRISPR-Cas9 Gene Editing Service Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe CRISPR-Cas9 Gene Editing Service Sales Value (2021-2032)
- 6.4.2 Europe CRISPR-Cas9 Gene Editing Service Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific CRISPR-Cas9 Gene Editing Service Sales Value (2021-2032)
- 6.5.2 Asia-Pacific CRISPR-Cas9 Gene Editing Service Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America CRISPR-Cas9 Gene Editing Service Sales Value (2021-2032)
- 6.6.2 South America CRISPR-Cas9 Gene Editing Service Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa CRISPR-Cas9 Gene Editing Service Sales Value (2021-2032)
- 6.7.2 Middle East & Africa CRISPR-Cas9 Gene Editing Service Sales Value Share by Country, 2025 VS 2032
7 CRISPR-Cas9 Gene Editing Service Country-level Value Analysis
- 7.1 Global CRISPR-Cas9 Gene Editing Service Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global CRISPR-Cas9 Gene Editing Service Sales Value by Country (2021-2032)
- 7.2.1 Global CRISPR-Cas9 Gene Editing Service Sales Value by Country (2021-2026)
- 7.2.2 Global CRISPR-Cas9 Gene Editing Service Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032)
- 7.3.2 USA CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032)
- 7.7.2 France CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032)
- 7.14.2 China CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032)
- 7.17.2 India CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt CRISPR-Cas9 Gene Editing Service Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt CRISPR-Cas9 Gene Editing Service Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt CRISPR-Cas9 Gene Editing Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 AMSBIO
- 8.1.1 AMSBIO Company Information
- 8.1.2 AMSBIO Business Overview
- 8.1.3 AMSBIO CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (2021-2026)
- 8.1.4 AMSBIO CRISPR-Cas9 Gene Editing Service Product Portfolio
- 8.1.5 AMSBIO Recent Developments
- 8.2 GenScript
- 8.2.1 GenScript Company Information
- 8.2.2 GenScript Business Overview
- 8.2.3 GenScript CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (2021-2026)
- 8.2.4 GenScript CRISPR-Cas9 Gene Editing Service Product Portfolio
- 8.2.5 GenScript Recent Developments
- 8.3 Merck
- 8.3.1 Merck Company Information
- 8.3.2 Merck Business Overview
- 8.3.3 Merck CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (2021-2026)
- 8.3.4 Merck CRISPR-Cas9 Gene Editing Service Product Portfolio
- 8.3.5 Merck Recent Developments
- 8.4 Editas Medicine
- 8.4.1 Editas Medicine Company Information
- 8.4.2 Editas Medicine Business Overview
- 8.4.3 Editas Medicine CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (2021-2026)
- 8.4.4 Editas Medicine CRISPR-Cas9 Gene Editing Service Product Portfolio
- 8.4.5 Editas Medicine Recent Developments
- 8.5 Intellia Therapeutics
- 8.5.1 Intellia Therapeutics Company Information
- 8.5.2 Intellia Therapeutics Business Overview
- 8.5.3 Intellia Therapeutics CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (2021-2026)
- 8.5.4 Intellia Therapeutics CRISPR-Cas9 Gene Editing Service Product Portfolio
- 8.5.5 Intellia Therapeutics Recent Developments
- 8.6 CRISPR Therapeutics
- 8.6.1 CRISPR Therapeutics Company Information
- 8.6.2 CRISPR Therapeutics Business Overview
- 8.6.3 CRISPR Therapeutics CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (2021-2026)
- 8.6.4 CRISPR Therapeutics CRISPR-Cas9 Gene Editing Service Product Portfolio
- 8.6.5 CRISPR Therapeutics Recent Developments
- 8.7 DefiniGEN
- 8.7.1 DefiniGEN Company Information
- 8.7.2 DefiniGEN Business Overview
- 8.7.3 DefiniGEN CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (2021-2026)
- 8.7.4 DefiniGEN CRISPR-Cas9 Gene Editing Service Product Portfolio
- 8.7.5 DefiniGEN Recent Developments
- 8.8 Synthego
- 8.8.1 Synthego Company Information
- 8.8.2 Synthego Business Overview
- 8.8.3 Synthego CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (2021-2026)
- 8.8.4 Synthego CRISPR-Cas9 Gene Editing Service Product Portfolio
- 8.8.5 Synthego Recent Developments
- 8.9 Biocytogen
- 8.9.1 Biocytogen Company Information
- 8.9.2 Biocytogen Business Overview
- 8.9.3 Biocytogen CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (2021-2026)
- 8.9.4 Biocytogen CRISPR-Cas9 Gene Editing Service Product Portfolio
- 8.9.5 Biocytogen Recent Developments
- 8.10 Caribou
- 8.10.1 Caribou Company Information
- 8.10.2 Caribou Business Overview
- 8.10.3 Caribou CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (2021-2026)
- 8.10.4 Caribou CRISPR-Cas9 Gene Editing Service Product Portfolio
- 8.10.5 Caribou Recent Developments
- 8.11 Horizon Discovery Ltd.
- 8.11.1 Horizon Discovery Ltd. Company Information
- 8.11.2 Horizon Discovery Ltd. Business Overview
- 8.11.3 Horizon Discovery Ltd. CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (2021-2026)
- 8.11.4 Horizon Discovery Ltd. CRISPR-Cas9 Gene Editing Service Product Portfolio
- 8.11.5 Horizon Discovery Ltd. Recent Developments
- 8.12 EdiGene, Inc.
- 8.12.1 EdiGene, Inc. Company Information
- 8.12.2 EdiGene, Inc. Business Overview
- 8.12.3 EdiGene, Inc. CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (2021-2026)
- 8.12.4 EdiGene, Inc. CRISPR-Cas9 Gene Editing Service Product Portfolio
- 8.12.5 EdiGene, Inc. Recent Developments
- 8.13 DetaiBio
- 8.13.1 DetaiBio Company Information
- 8.13.2 DetaiBio Business Overview
- 8.13.3 DetaiBio CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (2021-2026)
- 8.13.4 DetaiBio CRISPR-Cas9 Gene Editing Service Product Portfolio
- 8.13.5 DetaiBio Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,250USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst